Cargando…
Can the prophylactic quadrivalent HPV vaccine be used as a therapeutic agent in women with CIN? A randomized trial
BACKGROUND: Human papillomavirus (HPV) is one of the most significant risk factors for cervical cancer. The HPV vaccine has a very significant impact on the incidence of cervical cancer. The present study aimed to investigate the impact of prophylactic quadrivalent HPV vaccine in the treatment of wo...
Autores principales: | Karimi-Zarchi, Mojgan, Allahqoli, Leila, Nehmati, Ameneh, Kashi, Abolfazl Mehdizadeh, Taghipour-Zahir, Shokouh, Alkatout, Ibrahim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045378/ https://www.ncbi.nlm.nih.gov/pubmed/32106837 http://dx.doi.org/10.1186/s12889-020-8371-z |
Ejemplares similares
-
Gynecological cancers and the global COVID-19 pandemic
por: Alkatout, Ibrahim, et al.
Publicado: (2020) -
Women with gynecologic cancers need more psychological attention during the COVID-19 pandemic
por: Allahqoli, Leila, et al.
Publicado: (2021) -
Hemoperitoneum due to bleeding from a vein overlying a subserous uterine myoma: a case report
por: Rokhgireh, Samaneh, et al.
Publicado: (2020) -
Comparison of Pap Smear and Colposcopy in Screening for Cervical Cancer in Patients with Secondary Immunodeficiency
por: Karimi-zarchi, Mojgan, et al.
Publicado: (2015) -
The Diagnostic Accuracy of Combined Enolase/Cr, CA125, and CA19-9 in the Detection of Endometriosis
por: Rokhgireh, Samaneh, et al.
Publicado: (2020)